How do patients actually feel after PFA compared with thermal AF ablation? 🤔
In our PROMs-PFA study, PFA was associated with less early chest pain although differences resolved by 30 days.
@JCardioEP paper🔗 https://t.co/WRbeS74rLD
@DhirajGuptaBHRS@vish_luther#EPeeps
📣 Substantive EP & Devices consultant post now advertising in the world renowned Liverpool Heart and Chest Hospital @LHCHFT@LiverpoolEP
Looking especially for candidates to support the clinical & academic structural heart VT programme
Apply now👇
https://t.co/DU4RNuuFET
Our new #EP Clinical Compendium featuring clinical summaries and technical notes on FARAPULSE™, POLARx™, INTELLANAV STABLEPOINT™ and RHYTHMIA HDx™.
You can't miss it, download now: https://t.co/8NQqqTzwS4
#Epeeps
Join our upcoming webinar as a panel experts discuss the impact of PFA catheter design on clinical experience and outcomes. Register: https://t.co/0hlzPdPJNN
CAUTION: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.
> 93% first pass isolation rate per vein in PVI with #STABLEPOINT™ catheter.
Dr. Lepillier explains the results from a large prospective international multi-center trial shown at #EHRA2023.
More here on "Lesion creation guided by local impedance": https://t.co/78dXkxUujX
#Epeeps
Join our live webinar on the 11th of May for an opportunity to learn about the latest clinical data on local impedance and how experts are using it in their daily practice.
We look forward to seeing you there!
Register here: https://t.co/e3yyQZc3JT
RIO 2022 Symposium!👨🏫
Personalised AF solutions: At the Dawn of the PFA Era | 1 December 2022, 17:35 CET
Register FREE➡️https://t.co/effBKRuL60
Join experts @DhirajGuptaBHRS @BorisSchmidt5 and @RolandTilz to explore solutions, patient management and clinical results!
Right Power, Right Duration: a point-by-point 45–50W power workflow when local #impedance guidance is combined with #force within #STABLEPOINT may lead to a significant reduction in RF delivery time while enabling safe and effective lesions. Learn more: https://t.co/9AVSxh4140
In one week, Sep 27 @ 5pm CET, leading global experts in the PFA domain will review PFA biophysics and clinical data outcomes during an independent, third-party, CME accredited, educational webinar provided by MediaSphere and Cine-Med.
Register here: https://t.co/6WsuVg0icA
Registration is now open for New Horizons in AF - the most important educational event of the year in AF. Experts will discuss and explore novel approaches and ground-breaking advances in #AF therapy.
Secure your ticket here: https://t.co/gGYyrbIrYF
#NHAF2022#BSCEMEA#epeeps